• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹及其代谢产物去乙基氯喹在人体血细胞中的分布及其对血清和血浆中这些化合物定量测定的意义。

Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.

作者信息

Bergqvist Y, Domeij-Nyberg B

出版信息

J Chromatogr. 1983 Jan 14;272(1):137-48. doi: 10.1016/s0378-4347(00)86110-1.

DOI:10.1016/s0378-4347(00)86110-1
PMID:6841533
Abstract

The amount of chloroquine and desethyl-chloroquine was determined in samples of total blood and in blood cell fractions from three normal subjects after one oral dose of 1000 mg of chloroquine diphosphate. About 70-85% of the total whole blood content of chloroquine and its metabolite desethyl-chloroquine were recovered in blood cells isolated from whole blood, indicating that these compounds have a high cell/plasma concentration ratio. They were mainly present in thrombocytes and granulocytes. A study of 40 patients taking chloroquine regularly as a treatment for rheumatoid arthritis showed significantly higher concentrations of chloroquine and desethyl-chloroquine in serum than in plasma. The concentration of chloroquine was about two times higher in serum than in plasma and for desethyl-chloroquine the concentration was about four times higher in serum than in plasma. These differences may be explained by a release of chloroquine and desethyl-chloroquine from thrombocytes during the coagulation of blood. The practical implication of the results is that the samples taken for chloroquine determination must be clearly identified as serum or plasma.

摘要

给三名正常受试者口服1000毫克磷酸氯喹单剂量后,测定了全血样本及血细胞组分中的氯喹和去乙基氯喹含量。从全血中分离出的血细胞中回收了约70 - 85%的氯喹及其代谢产物去乙基氯喹的全血含量,这表明这些化合物具有较高的细胞/血浆浓度比。它们主要存在于血小板和粒细胞中。一项对40例定期服用氯喹治疗类风湿性关节炎患者的研究表明,血清中氯喹和去乙基氯喹的浓度显著高于血浆。氯喹在血清中的浓度约为血浆中的两倍,而去乙基氯喹在血清中的浓度约为血浆中的四倍。这些差异可能是由于血液凝固过程中血小板释放氯喹和去乙基氯喹所致。结果的实际意义在于,用于氯喹测定的样本必须明确标识为血清或血浆。

相似文献

1
Distribution of chloroquine and its metabolite desethyl-chloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma.氯喹及其代谢产物去乙基氯喹在人体血细胞中的分布及其对血清和血浆中这些化合物定量测定的意义。
J Chromatogr. 1983 Jan 14;272(1):137-48. doi: 10.1016/s0378-4347(00)86110-1.
2
Distribution of chloroquine in human blood fractions.氯喹在人体血液各组分中的分布。
Methods Find Exp Clin Pharmacol. 1988 Sep;10(9):581-7.
3
[Distribution of chloroquine and desethylchloroquine in blood, plasma and erythrocytes of healthy subjects and malaria patients. Assay using HPLC].[氯喹和去乙基氯喹在健康受试者及疟疾患者血液、血浆和红细胞中的分布。采用高效液相色谱法进行测定]
Pathol Biol (Paris). 1984 May;32(5):359-61.
4
Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography.高效液相色谱法测定人血浆和尿液中氯喹及其代谢物去乙基氯喹的灵敏方法。
J Chromatogr. 1980 Nov 14;221(1):119-27. doi: 10.1016/s0378-4347(00)81013-0.
5
Comparison of the partitioning in vitro of chloroquine and its desethyl metabolites between the erythrocytes and plasma of healthy subjects and those with falciparum malaria.健康受试者和恶性疟患者红细胞与血浆中氯喹及其去乙基代谢物的体外分配比较。
Afr J Med Med Sci. 1989 Jun;18(2):95-100.
6
Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.采用液相色谱法测定血浆、红细胞和尿液中的氯喹及其去乙基代谢物。
J Chromatogr. 1982 Apr 16;229(1):241-7. doi: 10.1016/s0378-4347(00)86059-4.
7
Determination of chloroquine and its desethyl metabolite in whole blood: an application for samples collected in capillary tubes and dried on filter paper.
Ther Drug Monit. 1985;7(2):207-10. doi: 10.1097/00007691-198506000-00012.
8
Disposition of chloroquine in man after single intravenous and oral doses.单次静脉注射和口服剂量后氯喹在人体内的处置情况。
Br J Clin Pharmacol. 1983 Apr;15(4):471-9. doi: 10.1111/j.1365-2125.1983.tb01532.x.
9
Chloroquine excretion following malaria prophylaxis.疟疾预防后氯喹的排泄情况。
Br J Clin Pharmacol. 1987 Aug;24(2):221-4. doi: 10.1111/j.1365-2125.1987.tb03165.x.
10
Whole-blood single-dose kinetics of chloroquine and desethylchloroquine in Africans.非洲人氯喹和去乙基氯喹的全血单剂量动力学
Ther Drug Monit. 1986;8(2):195-9. doi: 10.1097/00007691-198606000-00012.

引用本文的文献

1
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.回归SARS-CoV-2生物化学的基础:微血管闭塞性聚糖结合决定其发病机制并为治疗反应提供依据。
Viruses. 2024 Apr 22;16(4):647. doi: 10.3390/v16040647.
2
A Case of Self-salvation in a Determined Chloroquine Suicide Attempt.一例决心服用氯喹自杀未遂后的自我挽救病例
J Crit Care Med (Targu Mures). 2021 Nov 13;8(1):61-65. doi: 10.2478/jccm-2021-0036. eCollection 2022 Jan.
3
HPLC methods for choloroquine determination in biological samples and pharmaceutical products.
用于测定生物样品和药品中氯喹的高效液相色谱法。
Daru. 2021 Jun;29(1):223-239. doi: 10.1007/s40199-021-00391-y. Epub 2021 Mar 19.
4
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.对 COVID-19 感染新治疗领域的药代动力学(PK)和药代动力学-药效学(PK-PD)研究的关注。
Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10.
5
Population Pharmacokinetics and Pharmacodynamics of Chloroquine in a Plasmodium vivax Volunteer Infection Study.人群药代动力学和氯喹在间日疟原虫志愿者感染研究中的药效动力学。
Clin Pharmacol Ther. 2020 Nov;108(5):1055-1066. doi: 10.1002/cpt.1893. Epub 2020 Jul 2.
6
Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.氯喹治疗 2019 新型冠状病毒病:独特的药代动力学和安全性特征的影响。
Clin Pharmacokinet. 2020 Jun;59(6):659-669. doi: 10.1007/s40262-020-00891-1.
7
High sensitivity methods to quantify chloroquine and its metabolite in human blood samples using LC-MS/MS.使用液相色谱-串联质谱法(LC-MS/MS)定量测定人血样中氯喹及其代谢物的高灵敏度方法。
Bioanalysis. 2019 Mar;11(5):333-347. doi: 10.4155/bio-2018-0202. Epub 2019 Mar 15.
8
Population Pharmacokinetic Estimates Suggest Elevated Clearance and Distribution Volume of Desethylamodiaquine in Pediatric Patients with Sickle Cell Disease Treated with Artesunate-Amodiaquine.群体药代动力学估计表明,接受青蒿琥酯-阿莫地喹治疗的镰状细胞病儿科患者中去乙基阿莫地喹的清除率和分布容积升高。
Curr Ther Res Clin Exp. 2019 Jan 12;90:9-15. doi: 10.1016/j.curtheres.2019.01.005. eCollection 2019.
9
A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.在加纳患有急性非复杂性疟疾的镰状细胞病和非镰状细胞病儿科患者中,青蒿琥酯-阿莫地喹与蒿甲醚-本芴醇的随机试验。
Malar J. 2014 Sep 19;13:369. doi: 10.1186/1475-2875-13-369.
10
Chloroquine-induced Pruritus.氯喹引起的瘙痒。
Indian J Pharm Sci. 2010 May;72(3):283-9. doi: 10.4103/0250-474X.70471.